推荐应用
Axl, also known as Ufo and Ark, is a widely expressed 140 kDa glycoprotein in the TAM receptor tyrosine kinase family. TAM family receptors (Dtk/Tyro3, Axl, and Mer) are involved in regulation of the inflammatory response, cell survival and migration, and tumorigenesis. Mature human Axl consists of a 426 aa extracellular domain (ECD) that contains two Ig-like domains and two fibronectin type III domains, a 21 aa transmembrane segment, and a 422 aa cytoplasmic domain that includes the tyrosine kinase domain. Within the ECD, human Axl shares approximately 82% aa sequence identity with mouse and rat Axl. A short alternately spliced form of human Axl has a 9 aa deletion in the extracellular juxtamembrane region. Axl binds the vitamin K-dependent protein Gas6 which triggers tyrosine autophosphorylation of the Axl cytoplasmic domain. Activation of Axl induces a broad range of activities including platelet aggregation and thrombus formation, macrophage and dendritic cell phagocytosis of apoptotic cells, NK cell development from hematopoietic progenitor cells, and in vivo angiogenesis. Axl is highly expressed in solid cancers and promotes in vivo tumorigenesis and tumor cell invasiveness. It contributes to vascular remodeling and inflammatory cell infiltration in response to hypertension and restricted blood flow. It also functions as a cellular entry receptor for Gas6-opsonized lentiviruses. A 70-80 kDa soluble portion of the Axl ECD can be shed by proteolytic cleavage, and this fragment retains the ability to bind Gas6.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
142
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
145
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
181
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
141
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1918
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1883
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1144
2026-04-22
【应用方向】TNFR蛋白家族概述
1090
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1261
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
940
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
958
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1032
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
867
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19442
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11686
2025-07-09





